In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

Dr. Debu Tripathy explains how ctDNA is used to in breast cancer detection and how it can also indicate the presence of MRD.

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.

A new Yale study has found evidence to support the value of a tool that measures the presence of cancer -derived molecules in ...

Conversely, MRD could also identify patients with low risk of recurrence, possibly sparing them from further treatment and any associated drug toxicities as a result.

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of ...

Treatment Blood Test Offers New Hope for Personalized Cancer Therapy DecisionsA new Yale study has found evidence to support ...

Oncologists are increasingly favoring CAR T-cell therapy’s early-line use in relapsed/refractory multiple myeloma despite ...

Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 ...